HyperMed Imaging, Inc. is a privately owned medical device company and the market leader in hyperspectral medical imaging. HyperMed pioneered the use of its novel version of hyperspectral imaging for assessment of superficial tissue oximetry with its OxyVu-1 device, first cleared by the FDA in 2006. HyperMed currently has over 35 issued patents and more than 40 additional patents pending worldwide on its hyperspectral medical imaging technology and associated products.
Company’s Keywords:
hyperspectral imaging
<4
<6000000
<2012